UVLrx Therapeutics Flagged for IDE Violations

Clinical Trials Advisor
A A
The FDA warned investigational medical device sponsor UVLrx Therapeutics for failing to obtain required authorization from its Institutional Review Board.

To View This Article:

Login

Subscribe To Clinical Trials Advisor